A detailed history of Y Intercept (Hong Kong) LTD transactions in Insmed Inc stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 224,302 shares of INSM stock, worth $36.2 Million. This represents 0.6% of its overall portfolio holdings.

Number of Shares
224,302
Holding current value
$36.2 Million
% of portfolio
0.6%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 01, 2025

BUY
$64.81 - $105.9 $14.5 Million - $23.8 Million
224,302 New
224,302 $22.6 Million
Q2 2024

Aug 14, 2024

BUY
$22.0 - $69.71 $340,560 - $1.08 Million
15,480 Added 206.07%
22,992 $1.54 Million
Q1 2024

May 10, 2024

SELL
$25.72 - $29.94 $456,735 - $531,674
-17,758 Reduced 70.27%
7,512 $203,000
Q4 2023

Feb 13, 2024

BUY
$23.42 - $31.74 $210,475 - $285,247
8,987 Added 55.19%
25,270 $783,000
Q3 2023

Nov 14, 2023

BUY
$19.86 - $26.93 $130,857 - $177,441
6,589 Added 67.97%
16,283 $411,000
Q2 2023

Aug 14, 2023

BUY
$16.44 - $21.1 $159,369 - $204,543
9,694 New
9,694 $204,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $21.9B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Y Intercept (Hong Kong) LTD Portfolio

Follow Y Intercept (Hong Kong) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.